sarscoronaviru
cov
zoonot
agent
deriv
rhinolophid
bat
plethora
sarsrel
conspecif
viral
lineag
exist
wherea
variabl
virul
among
reservoirborn
virus
unknown
gener
assum
emerg
epidem
virus
anim
reservoir
requir
human
adapt
understand
influenc
viral
factor
relat
interspeci
spillov
studi
papainlik
proteas
plp
sarscov
key
enzym
drive
earli
stage
infect
cleav
viral
polyprotein
deubiquitin
viral
cellular
protein
antagon
interferon
ifn
respons
identifi
bat
sarscov
plp
share
amino
acid
ident
sarscov
plp
use
revers
genet
insert
sarscov
genom
result
viru
replic
like
sarscov
vero
cell
suppress
ifn
compet
human
airway
epitheli
cell
use
ectopicallyexpress
plp
variant
well
full
sarscov
infecti
clone
chimer
plp
found
proteaseindepend
antiifn
function
exist
sarscov
sarsrel
batborn
viru
plpmediat
antiifn
differ
seen
primat
human
well
bat
cell
thu
independ
host
context
result
studi
reveal
coronaviru
plp
confer
variabl
virul
trait
among
member
speci
sarscov
sarscov
lineag
virul
plp
may
preexist
reservoir
onset
epidem
coronavirus
cov
famili
coronavirida
among
relev
group
virus
zoonot
potenti
cov
larg
positivesens
singlestrand
rna
virus
caus
acut
prolong
infect
varieti
mammal
bird
pathogen
human
cov
includ
member
genu
alphacoronaviru
term
human
coronaviru
hcov
well
member
genu
betacoronaviru
term
endem
virus
caus
upper
lower
respiratori
tract
infect
human
worldwid
past
zoonot
descent
infer
respect
actual
zoonot
acquisit
known
two
betacoronavirus
caus
sever
lung
diseas
human
middl
east
respiratori
syndrom
coronaviru
merscov
zoonot
agent
frequent
repeatedli
acquir
human
upon
contact
dromedari
camel
arabian
peninsula
part
africa
viru
seem
caus
limit
humantohuman
transmiss
consid
major
threat
global
public
health
due
recur
nosocomi
outbreak
may
facilit
onward
adapt
human
sever
acut
respiratori
syndrom
sar
cov
caus
epidem
sustain
humantohuman
transmiss
china
countri
involv
notifi
infect
case
fatal
proport
human
sar
case
deriv
least
two
independ
zoonot
transmiss
put
intermediari
reservoir
feral
carnivor
major
case
part
one
continu
chain
humantohuman
transmiss
bat
known
harbor
sarscov
strain
directli
infect
primat
cell
sarscov
becom
paradigmat
subject
studi
prepandem
process
ecolog
molecular
level
due
zoonot
natur
mani
cov
increas
interest
understand
function
differ
rel
way
virus
deal
host
cell
defens
across
differ
host
speci
particularli
innat
immun
respons
mediat
type
interferon
reservoirborn
virus
therefor
necessari
help
us
determin
differ
intrins
virul
virushost
interact
view
complex
plp
interact
innat
immun
function
studi
take
whole
viral
replic
cycl
account
date
dub
function
sarscov
plp
studi
context
replic
viru
moreov
studi
far
compar
plp
function
member
one
viral
speci
includ
natur
variant
exist
zoonot
reservoir
differ
reservoirborn
epidem
virus
may
uncov
mechan
aid
viral
emerg
potenti
pandem
strain
base
epidem
reservoirborn
variant
speci
sarscov
exemplifi
function
differ
plp
domain
revers
genet
show
plp
epidem
sarscov
enhanc
ifn
antagonist
function
independ
plp
proteas
activ
present
plp
batassoci
sarscov
addit
mutagenesi
studi
replic
viru
context
associ
function
differ
effici
bind
ubiquitin
ubiquitinlik
modifi
gener
assumpt
reservoirassoci
virus
highli
adapt
host
find
plp
human
epidem
viru
counteract
ifn
better
batderiv
plp
even
bat
cell
plp
function
viral
virul
trait
vari
among
reservoirborn
virus
earlier
studi
describ
sarsrel
cov
european
bulgarian
bat
speci
belong
genu
rhinolophu
fig
show
phylogeni
sarsrel
betacov
base
plp
gene
bp
fragment
genom
posit
genbank
access
number
base
stand
classif
criteria
european
batderiv
cov
conspecif
human
sarscov
sister
relationship
asian
sarsrel
cov
addit
close
relat
virus
conspecif
sarscov
repres
closest
phylogenet
outgroup
speci
sarsrel
cov
discov
ghanaian
hipposidero
bat
hipposidero
repres
sister
genu
typic
sarscov
host
rhinolophu
fig
plp
human
sarscov
henceforth
refer
saplp
plp
conspecif
european
bat
viru
srplp
sarsrel
plp
sister
speci
viru
soplp
sar
outgroup
amino
acid
sequenc
align
plp
region
show
obviou
similar
saplp
srplp
less
plp
soplp
plp
core
domain
saplp
srplp
compris
amino
acid
soplp
amino
acid
saplp
srplp
amino
acid
ident
soplp
share
posit
includ
insertionsdelet
posit
includ
insertionsdelet
ident
amino
acid
saand
srplp
respect
tabl
catalyt
triad
consist
three
residu
cystein
histidin
aspart
acid
previous
shown
respons
cleavag
sarscov
replicas
polyprotein
present
srplp
fig
grey
arrow
soplp
aspart
acid
replac
asparagin
n
altern
type
catalyt
domain
previous
describ
cystein
proteas
anoth
indispens
featur
saplp
zincbind
domain
compris
four
cystein
residu
connect
leftand
righthand
domain
papainlik
fold
zinc
atom
residu
also
present
within
srand
soplp
amino
acid
sequenc
fig
mark
asterisk
function
compar
plp
proteas
activ
assess
transcleavag
assay
assay
base
coexpress
sarscov
substrat
respect
plp
test
cleavag
substrat
truncat
product
establish
assay
notic
consider
level
mrna
splice
express
srplp
control
chicken
promot
fig
codonoptim
construct
therefor
gener
truncat
product
detect
western
blot
use
antigfp
epitop
tag
antibodi
plp
fig
lane
confirm
proteas
activ
srplp
soplp
depend
typic
catalyt
domain
saplp
catalyt
cystein
plp
chang
alanin
saplp
mutat
previous
shown
abolish
plp
activ
mutant
henceforth
refer
camut
expect
plp
camut
unabl
process
sar
substrat
fig
lane
confirm
plp
express
case
western
blot
done
cell
lysat
use
antibodi
direct
flag
epitop
tag
fuse
plp
found
express
level
plp
equal
fig
lower
panel
enabl
quantit
comparison
proteas
activ
plp
biosensor
luciferas
assay
done
split
firefli
luciferas
coexpress
togeth
plp
interest
upon
cleavag
lxgg
proteas
cleavag
site
split
luciferas
construct
luciferas
activ
reconstitut
measur
equilibr
cell
membranepenetr
luciferas
substrat
timecours
experi
confirm
plp
similar
proteas
activ
rang
within
h
compar
camut
correspond
plp
fig
investig
amino
acid
differ
plp
affect
stereostructur
catalyt
site
small
molecul
competit
inhibitor
known
specif
plp
catalyt
site
name
test
sidebysid
plp
inhibit
proteas
activ
inhibitor
success
saplp
srplp
indic
structur
similar
catalyt
site
inhibitor
slightli
effici
saplp
ec
srplp
ec
plausibl
inhibitor
design
target
betaloop
structur
saplp
locat
close
catalyt
site
proteas
fig
inhibitor
low
effici
toward
soplp
whose
inhibitorbind
site
amino
acid
ident
amino
acid
ident
saplp
inhibitor
target
site
saplp
fig
compar
dub
activ
cell
cotransfect
increas
dose
plasmid
encod
plp
along
constant
dose
plasmid
encod
hatag
ubiquitin
decreas
protein
ubiquitin
confer
plp
determin
western
blot
ident
similar
list
protein
base
amino
acid
align
use
substitut
matrix
threshold
http
use
antiha
antibodi
plp
deconjug
ubiquitin
dosedepend
manner
suggest
plp
compar
dub
effici
fig
known
saplp
deisgyl
activ
effici
deconjug
cellular
protein
determin
deisgyl
assay
plp
coexpress
myctag
cell
extent
deisgyl
protein
cell
transfect
empti
vector
plasmid
ev
plasmid
express
either
wild
type
wt
catalyt
mutant
ca
plp
sarscov
cotransfect
simultan
lysat
harvest
hour
post
transfect
hpt
gene
express
analyz
western
blot
b
biosensor
assay
appli
detect
plp
cleavag
activ
cell
cotransfect
pglo
firefli
luciferas
either
wtplp
ca
ev
plasmid
hpi
cell
incub
glosensor
reagent
luminesc
detect
c
investig
activ
spectrum
saplp
proteas
inhibitor
one
hour
glosensor
incub
compound
dmso
ad
plp
activ
analyz
relat
differ
amount
compound
h
post
treatment
valu
normal
respect
dmsotreat
wtplp
biosensor
assay
perform
triplic
repeat
three
time
independ
error
bar
indic
standard
deviat
mean
statist
signific
dmso
inhibitortr
cell
cell
transfect
caplp
respect
determin
use
oneway
anova
sidak
post
hoc
test
statist
signific
differ
indic
asterisk
p
signific
ns
p
signific
p
signific
p
highli
signific
cell
transfect
ev
plasmid
express
either
wtor
caplp
analysi
dub
activ
wtplp
plasmid
transfect
increas
amount
plasmid
ng
ng
ng
per
control
plasmid
ng
ev
caplp
transfect
comparison
haubiquitin
haub
coexpress
sampl
lysat
harvest
hpt
gene
express
analyz
western
blot
e
analysi
deisgyl
activ
conjug
machineri
coexpress
sampl
lysat
harvest
hpt
gene
express
analyz
western
blot
western
blot
experi
repeat
three
time
independ
one
repres
blot
shown
appli
load
control
http
papainlik
proteas
vari
among
sarscoronaviru
speci
determin
western
blot
use
antimyc
antibodi
plp
highli
effici
deconjug
cellular
protein
fig
taken
togeth
result
suggest
compar
level
proteas
activ
ident
dub
deisgyl
activ
saand
srplp
overexpress
human
cell
context
differenti
effici
toward
plp
inhibitor
hint
structur
differ
even
plp
conspecif
virus
occur
zoonot
reservoir
howev
complet
failur
inhibitor
seen
soplp
fall
outsid
limit
current
cov
speci
classif
quantit
compar
function
two
close
relat
plp
saand
srplp
context
full
viru
replic
cycl
construct
chimer
sarscov
saplp
replac
srplp
fig
viral
plaqu
similar
morpholog
observ
recombin
wild
type
viru
rscv
fig
chimer
viru
srplprscv
fig
indic
srplp
abl
function
compens
saplp
alreadi
suggest
proteas
cleavag
assay
srplprscv
slightli
less
sensit
proteas
inhibitor
saplprscv
rscv
ic
srplprscv
ic
provid
addit
evid
function
structur
integr
srplp
context
sarscov
replic
fig
exclud
possibl
cytotox
cell
viabil
assay
conduct
number
viabl
cell
decreas
increas
amount
inhibitor
minimum
highest
dose
fig
confirm
specif
action
obtain
quantit
comparison
saand
srplp
viru
replic
multistep
growth
curv
experi
done
virus
vero
cell
virus
grew
titer
test
time
point
rang
pfuml
fig
notabl
growth
curv
differ
virus
grown
type
ifncompet
primat
cell
line
srplprscv
grew
significantli
lower
titer
rscv
gener
linear
regress
model
p
differ
hpi
hpi
fig
reduc
growth
srplprscv
cell
may
indic
less
effici
viral
counteract
type
ifn
order
compar
ifn
sensit
virus
vero
cell
treat
defin
concentr
panspeci
significantli
increas
ifn
sensit
iuml
p
twosid
test
compar
rscv
confirm
antiifn
activ
srplp
decreas
primat
cell
fig
confirm
growth
srplprscv
also
reduc
context
human
cell
environ
perform
multistep
growth
curv
experi
type
ifn
compet
human
lung
epitheli
cell
line
fig
srplprscv
grew
significantli
lower
titer
rscv
fold
hpi
p
fold
hpi
p
twosid
test
increas
detect
mrna
express
level
srplprscvcompar
rscvinfect
cell
confirm
srplp
less
effici
block
ifn
induct
fig
better
reflect
human
respiratori
tract
gener
notion
srplprscv
grow
less
effici
presenc
activ
type
ifn
respons
multistep
growth
curv
experi
conduct
human
airway
epitheli
cell
hae
accord
previou
studi
viru
growth
gener
delay
hae
compar
monoclon
primat
human
cell
cultur
importantli
significantli
reduc
growth
detect
srplprscv
compar
rscv
hpi
fold
p
twosid
test
provid
confirm
antiifn
activ
srplp
may
decreas
type
ifn
compet
cell
fig
treatment
experi
fig
would
broadli
affect
ifn
induct
signal
respons
plp
ifn
antagon
function
link
function
sensit
assay
nuclear
transloc
establish
nuclear
transloc
overexpress
fusion
protein
stimul
superinfect
rift
valley
fever
viru
clone
rvfv
cl
rvfvmutant
devoid
ifn
induct
antagonist
nss
rvfv
cl
known
trigger
strong
ifn
respons
proport
cell
nuclear
transloc
gfp
signal
count
microscop
summar
fig
ectop
express
saand
srplp
block
nuclear
transloc
compar
level
saplp
srplp
cellular
fusion
protein
locat
nucleu
soplp
outli
viru
block
nuclear
transloc
even
effici
cellular
fusion
protein
locat
nucleu
plp
camut
includ
experi
determin
whether
antiifn
effect
depend
proteas
function
inhibitori
capac
saand
soplp
camut
strongli
reduc
still
detect
signific
level
saplp
soplp
cell
fusion
protein
locat
nucleu
supernat
taken
hpi
viral
replic
determin
plaqu
titrat
assay
experi
perform
triplic
repeat
twice
error
bar
indic
standard
deviat
mean
one
repres
experi
shown
viru
growth
compar
ifncompet
human
cell
describ
experi
perform
triplic
e
determin
express
cell
infect
rscv
srplprscv
ifninduc
rvfv
cl
control
express
moi
total
mrna
extract
cell
lysat
hpi
express
determin
use
quantit
realtim
pcr
analysi
mean
fold
chang
express
calcul
use
tatabind
protein
tbp
express
refer
gene
analysi
method
experi
done
quadrupl
statist
signific
indic
group
determin
use
twosid
test
f
human
airway
epitheli
cell
hae
infect
rscv
srplprscv
absolut
infecti
dose
pfu
hpi
sampl
taken
viral
replic
determin
plaqu
titrat
assay
experi
done
duplic
repeat
three
time
independ
statist
signific
df
determin
use
twosid
test
http
contrast
srplp
camut
essenti
lost
abil
block
nuclear
transloc
cell
nuclear
signal
see
whether
plp
activ
transloc
determin
ifn
counteract
abil
block
ifn
promot
activ
compar
report
gene
assay
plp
effici
block
promot
activ
dosedepend
manner
residu
promot
activ
respect
plasmid
concentr
ng
saplp
srplp
soplp
fig
howev
differ
observ
camut
saplp
soplp
camut
still
block
promot
activ
dosedepend
manner
albeit
reduc
effici
compar
wild
type
saplp
fig
soplp
fig
residu
promot
activ
plasmid
concentr
ng
srplp
camut
lost
signific
block
function
promot
activ
fig
differenti
capabl
saplp
srplp
soplp
counteract
ifn
induct
may
attribut
differenti
capabl
inactiv
ubiquitin
ubiquitinlik
modifi
srplp
may
reli
proteasedepend
cleavag
saplp
soplp
may
abl
provid
addit
ifnantagonist
activ
bind
ubiquitin
ubiquitinlik
modifi
understand
within
sarsrcov
speci
saplp
compar
srplp
provid
addit
antiifn
activ
depend
ubiquitinbind
cleavag
decid
introduc
modif
ubiquitinbind
surfac
saplp
affect
proteaseprocess
activ
amino
acid
residu
saplp
interact
directli
bind
patch
compris
ubiquitin
base
cocrystal
studi
merscov
plp
replac
methionin
correspond
posit
bulkier
arginin
residu
found
prevent
interact
ectop
express
plp
ubiquitin
thu
decid
studi
effect
mutat
select
destabil
ubiquitinbind
sarscov
via
mutat
order
specif
focu
consequ
mutat
ifn
antagon
exclud
disturb
proteas
activ
plp
express
plasmid
gener
proteas
activ
compar
transcleavag
assay
confirm
mutat
impact
cleavag
activ
fig
plp
process
substrat
effici
saplp
confirm
ubiquitinbind
saplp
reduc
mutat
dub
assay
conduct
wild
type
saplp
express
plasmid
previous
describ
dub
effici
plp
fig
lane
reduc
compar
wild
type
plp
fig
lane
indic
increas
number
ubiquitin
protein
band
lane
reduc
ubiquitinbind
effici
result
decreas
ifnantagonist
activ
plp
thu
compar
promot
activ
report
gene
assay
correspond
ca
mutant
less
antiifn
activ
compar
saplp
fig
combin
ca
fig
right
black
column
result
complet
deplet
signific
antiifn
activ
explor
consequ
disturb
ubiquitinbind
viru
growth
mutat
introduc
rscv
expect
result
viru
term
grew
titer
similar
rscv
multistep
growth
curv
vero
cell
fig
observ
srplp
congruenc
wild
type
chang
virus
grown
type
ifn
compet
cell
cell
grew
fig
confirm
destabil
mutat
ubiquitinbind
domain
caus
increas
ifn
sensit
vero
cell
pretreat
iu
panspeci
fig
upon
treatment
growth
differ
virus
augment
confirm
significantli
increas
ifn
sensit
iuml
p
iuml
p
twosid
test
confirm
type
ifndepend
growth
differ
rscv
rscvplp
multistep
viru
growth
kinet
done
human
lung
epitheli
cell
line
fig
compar
wild
type
virusinfect
cell
mutat
led
significantli
lower
titer
cell
fold
hpi
p
fold
hpi
p
twosid
test
order
directli
detect
virusdepend
effect
gene
express
cell
infect
virus
moi
h
mrna
upregul
detect
quantit
real
time
rtpcr
assay
fig
determin
foldinduct
mrna
method
appli
tata
bind
protein
tbp
housekeep
gene
cell
pronounc
mrna
express
level
differ
rscv
hpi
p
twosid
test
compar
rscv
type
ifninduc
rvfv
cl
includ
mrna
express
control
show
cell
fulli
function
ifn
respons
phenotyp
similar
srplprscv
suggest
saplp
srplp
provid
addit
ifn
antagon
via
bind
ubiquitin
ubiquitinlik
modifi
ubiquitin
deriv
conserv
mammalian
speci
expect
ubiquitindepend
antiifn
activ
independ
host
speci
member
speci
sarscov
carri
bat
genu
rhinolophu
ifncompet
rhinolophu
alcyon
lung
epitheli
cell
rhilu
made
transgen
human
receptor
lentivir
transduct
infect
rscv
srplprscv
fig
multistep
growth
curv
srplprscv
grew
significantli
lower
titer
compar
rscv
lower
hpi
p
lower
hpi
p
respect
decreas
viral
growth
srplprscv
bat
cell
may
indic
effici
ifn
counteract
rscv
compar
srplprscv
ifncompet
cell
remark
growth
differ
even
promin
bat
cell
compar
ifn
compet
primat
cell
versu
cell
hpi
order
investig
growth
differ
bat
cell
reflect
differ
ifn
suppress
quantit
realtimepcr
assay
specif
rhinolophu
gene
establish
determin
specif
mrna
express
level
cell
infect
rscv
srplprscv
ifn
induct
control
rvfv
cl
moi
moi
experi
done
triplic
statist
signific
determin
use
twosid
test
h
determin
express
cell
infect
rscv
ifninduc
rvfv
cl
control
express
moi
total
mrna
extract
cell
lysat
hpi
express
determin
use
quantit
realtim
pcr
analysi
mean
fold
chang
express
calcul
use
tatabind
protein
tbp
express
refer
gene
analysi
method
experi
done
quadrupl
statist
signific
indic
group
determin
use
twosid
test
http
total
rna
extract
cell
lysat
hpi
determin
foldinduct
mrna
express
level
method
appli
housekeep
gene
comparison
rscv
srplprscv
infect
led
significantli
higher
express
level
fold
hpi
p
twosid
test
fig
summari
result
suggest
increas
ifn
sensit
srplp
independ
host
cell
speci
rhinolophu
bat
speci
import
understand
whether
virus
constitut
risk
human
infect
host
tropism
mainli
thought
determin
spike
protein
studi
shown
cov
popul
natur
reservoir
contain
plethora
spike
variant
includ
variant
directli
mediat
entri
human
cell
widespread
recombin
spike
protein
exchang
viral
genet
lineag
reservoir
spike
protein
may
suffici
repres
variabl
virul
trait
reservoir
studi
conserv
viral
function
relat
host
interact
focus
plp
multifunct
protein
drive
essenti
step
infect
cycl
includ
cleavag
viral
polyprotein
well
deubiquitin
deisgyl
latter
function
interfer
molecul
ifn
pathway
cytokin
product
unknown
extent
contribut
replic
phenotyp
sarscov
initi
comparison
plp
function
epidem
reservoirassoci
viru
base
ectopicallyexpress
protein
confirm
essenti
properti
cleavag
viral
polyprotein
sensit
known
inhibitor
almost
ident
epidemicand
reservoirderiv
plp
howev
overexpress
assay
reflect
whole
complex
viral
life
cycl
includ
time
compartment
function
detect
subtl
differ
expect
occur
natur
viru
variant
gener
infecti
clone
carri
reservoirderiv
plp
otherwis
cell
infect
rscv
srplprscv
ifninduc
rvfv
cl
control
mrna
express
moi
total
mrna
extract
cell
lysat
hpi
express
determin
use
quantit
realtim
pcr
analysi
mean
fold
chang
express
calcul
use
express
housekeepingrefer
gene
analysi
method
experi
done
quadrupl
repeat
twice
one
two
experi
shown
statist
signific
indic
group
determin
use
twosid
test
http
unmodifi
sarscov
backbon
growth
properti
chimer
viru
ifndefici
vero
cell
confirm
reservoirderiv
plp
effect
cleav
viral
polyprotein
support
recombin
viru
replic
kinet
compar
wild
type
sarscov
grown
cell
fulli
activ
ifn
system
wild
type
sarscov
replic
better
plpchimer
viru
small
signific
growth
differ
rang
hae
depend
time
point
post
infect
appli
cell
cultur
assum
viral
protein
ifn
antagonist
function
like
protein
might
compens
decreas
immunemodul
function
srplp
prevent
pronounc
growth
differ
importantli
show
effect
increas
artifici
ifn
ad
cell
cultur
addit
accompani
effici
block
mrna
upregul
obtain
confirm
specif
plp
function
within
ifn
respons
show
studi
catalyticallyinactiv
plp
construct
antiifn
function
reservoirderiv
srplp
depend
proteas
function
sarscov
plp
exert
addit
proteaseindepend
activ
ifn
evas
like
mechan
addit
activ
identifi
invitro
studi
involv
bind
ubiquitin
ubiquitinlik
modifi
confirm
function
link
dub
function
ifn
antagon
first
time
replic
cov
cytopathogen
natur
sarscov
infect
prevent
sensit
cellbas
assay
duband
deisgyl
function
reli
knowledg
structurefunct
relationship
studi
equin
arter
viru
eav
arteriviru
relat
cov
eav
ubiquitinbind
surfac
distinct
proteas
activ
site
identifi
mutagen
without
caus
loss
proteas
process
definit
link
ifn
antagon
establish
engin
destabil
mutat
ubiquitinbind
surfac
eav
infecti
clone
caus
increas
induct
ifn
replic
introduct
homolog
mutat
sarscov
infecti
clone
found
even
clearer
loss
ifn
antagon
eav
choic
mutat
inform
anoth
studi
defin
primari
ubiquitinbind
surfac
sarscov
plp
found
posit
critic
interact
conform
bind
patch
ubiquitin
affect
proteas
activ
concordantli
found
sign
catalyt
inactiv
mutant
vero
cell
replic
like
wild
type
viru
pattern
fulli
proteasedepend
ifn
antagon
like
reservoirderiv
plp
conclud
ubiquitin
bind
constitut
antiifn
function
sarscov
plp
independ
conserv
proteas
function
phenotyp
relev
replic
level
immun
evas
variabl
among
viral
variant
ifnrel
effect
observ
present
studi
seem
relev
resembl
effect
observ
upon
delet
activ
anoth
essenti
replicas
function
modifi
ifnrecognit
studi
mutat
domain
replic
like
wild
type
vero
cell
caus
lower
replic
ifncompet
human
airway
epitheli
cell
line
engin
mouseadapt
backbon
mutant
clear
faster
lung
infect
mice
caus
significantli
less
weight
loss
present
studi
use
vivo
model
evalu
consequ
introduc
mutat
replic
mous
experi
may
reflect
role
plp
host
switch
expect
import
ubiquitinlik
modifi
process
sarscov
plp
conserv
human
bat
mice
howev
deriv
exist
srplp
bat
ubiquitinrel
function
plp
essenti
sarscov
replic
natur
host
function
variant
reflect
natur
divers
suggest
sarscov
may
gain
virul
human
humantohuman
passag
adapt
differ
immun
interact
observ
present
studi
depend
host
cell
use
even
bat
cell
natur
host
sarscov
epidem
sarscov
addit
antiifn
activ
differenti
virul
via
plp
may
therefor
preexist
within
viral
reservoir
rather
evolv
posit
select
upon
adapt
within
human
host
therefor
postul
plp
variabl
virul
trait
among
member
speci
sarscov
exist
natur
reservoir
base
plp
structur
huge
potenti
natur
sequenc
variant
influenc
ubiquitinbind
instanc
plp
second
ubiquitinbind
site
enabl
bident
bind
mechan
may
explain
plp
prefer
diubiquitin
crystal
plp
complex
diubiquitin
identifi
structur
second
bind
site
seem
critic
diubiquitinbind
primari
bind
surfac
primari
ubiquitinbind
surfac
critic
bind
sarscov
strain
found
reservoir
china
europ
show
sever
variant
ubiquitinbind
site
could
studi
effect
replic
level
virul
trait
fig
silico
model
ubiquitinbind
site
saand
srplp
show
sequenc
variat
may
even
caus
structur
chang
inand
adjac
bind
site
fig
fact
apart
observ
function
differ
may
also
structur
chang
two
close
relat
plp
singl
viru
speci
speci
sarsrel
cov
particularli
intrigu
differ
previous
seen
among
cov
belong
differ
viru
genera
plp
exampl
similar
proteaseindepend
antiifn
function
plp
sarscov
wherea
merscov
plp
antiifn
activ
clearli
depend
proteas
function
exist
function
divers
reservoir
make
sens
light
viral
evolut
emerg
instanc
capac
modul
process
substrat
bind
separ
domain
plp
open
possibl
reservoirassoci
cov
adjust
fit
virul
level
base
chang
host
popul
structur
increas
virul
may
confer
increas
transmiss
rate
may
come
cost
host
popul
declin
base
data
seem
reservoir
contain
consider
degre
function
variabl
base
highli
conserv
host
function
ubiquitin
system
viru
adapt
human
host
may
evolv
properti
begin
viru
emerg
rather
reservoir
may
contain
preform
virul
trait
predict
experi
inform
detail
knowledg
molecular
viru
function
enabl
new
approach
forecast
emerg
potenti
fecal
pellet
hipposidero
bat
provid
author
christian
drosten
fecal
sampl
collect
noninvas
train
field
biologist
store
analysi
detail
bat
caught
mist
net
check
interv
min
captur
bat
freed
net
immedi
put
cotton
bag
sever
minut
kept
bag
bat
produc
fecal
pellet
collect
transfer
rnalat
rna
stabil
solut
qiagen
hilden
germani
procedur
previous
describ
consist
guidelin
american
societi
mammalogist
use
wild
mammal
research
nation
guidelin
captur
handl
care
bat
captur
sampl
sampl
export
permiss
obtain
wildlif
divis
ministri
land
forestri
mine
ghana
permit
describ
previous
primari
human
airway
epitheli
cell
procur
patient
underw
surgic
lung
resect
pulmonari
diseas
gave
inform
consent
done
accord
ethic
approv
eksg
eksg
kekb
schemat
represent
plp
amino
acid
sequenc
align
amino
acid
europeanand
chines
reservoirassoci
sarsrel
cov
strain
highlight
sequenc
divers
plp
domain
align
show
strain
repres
grey
line
uniqu
mutat
black
vertic
bar
ubiquitinbind
surfac
highlight
orang
magenta
respect
propos
local
depict
cartoon
align
saand
srplp
investig
present
studi
highlight
red
homolog
model
srplp
done
compar
interact
surfac
saand
srplp
respect
two
ubiquitin
molecul
diubiquitin
molecular
graphic
analyz
perform
ucsf
chimera
packag
crystal
structur
sarscov
plp
complex
diubiquitin
pdb
entri
templat
amino
acid
sequenc
srplp
target
put
amino
acid
contact
point
saand
srplp
b
c
highlight
conform
variabl
plp
ubiquitinbind
tertiari
structur
saplp
shown
dark
blue
srplp
tertiari
structur
shown
light
blue
http
friedemann
weber
univers
friedemann
weber
univers
vero
jindrich
cinatl
univers
frankfurt
vero
atcc
atcc
atcc
provid
author
marcel
cell
cultiv
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
thermofish
scientif
penicillinstreptomycin
nonessenti
amino
acid
lglutamin
sodium
pyruv
co
atmospher
hae
gener
maintain
previous
describ
rvfv
cl
kind
gift
friedemann
weber
univers
infect
experi
rscv
done
biosafeti
level
condit
enhanc
respiratori
person
protect
equip
ensur
high
level
protein
product
sa
srand
soplp
eukaryot
cell
codonusag
optim
base
human
codonusag
frequenc
addit
potenti
splice
site
polyadenyl
signal
sequenc
elimin
sequenc
clone
eukaryot
express
plasmid
pcagg
along
carboxytermin
flag
epitop
tag
region
saplp
pcr
amplifi
parent
plasmid
srand
soplp
synthes
geneart
primer
use
clone
list
tabl
site
direct
mutagenesi
done
chang
catalyt
cystein
alanin
quikchang
mutagenesi
replac
ubiquitinbind
residu
arginin
gibson
assembl
neb
use
indic
primer
tabl
insert
correct
mutat
verifi
dna
sequenc
pcaggshaub
prltk
plasmid
kindli
provid
ralph
baric
univers
north
carolina
usa
adriano
marches
medic
colleg
wisconsin
usa
minjung
kim
pohang
univers
republ
korea
karlklau
conzelmann
univers
munich
germani
kind
gift
robert
krug
univers
texa
usa
pcagg
previous
describ
synthesi
character
saplp
inhibitor
describ
soplp
sequenc
obtain
hipposidero
bat
fecal
sampl
previous
describ
pfefferl
et
al
accord
nucleotid
sequenc
align
contain
relat
plp
gene
sequenc
primer
locat
conserv
region
withinand
downstream
plp
domain
two
differ
primer
set
appli
two
success
perform
pcr
reaction
nucleotid
sequenc
inform
gain
use
design
primer
specif
target
soplp
sequenc
sequenc
strategi
primer
shown
tabl
srplprscv
construct
use
previous
establish
cdna
clone
approach
base
bacteri
artifici
chromosom
bac
keep
fulllength
cov
cdna
stabl
construct
fulllength
infecti
cdna
clone
seven
subclon
refer
pb
pc
pd
pe
pf
cover
whole
sarscov
genom
gener
assembl
stepwis
procedur
gener
srplprscv
chimer
srplp
subclon
name
contain
approxim
onehalf
sarscov
genom
desir
srplp
replac
use
join
subclon
pdef
fulllength
bac
cdna
clone
rescu
srplprscv
sequenc
confirm
presenc
srplp
absenc
mutat
follow
primer
primer
revers
transcript
brev
sequenc
primer
cell
seed
concentr
cellsml
h
viru
stock
dilut
serumfre
medium
accord
desir
moi
viru
adsorpt
ml
viru
master
mix
ad
cell
incub
h
h
viru
dilut
remov
well
wash
twice
pb
refil
supplement
dmem
supernat
taken
indic
time
point
studi
infect
hae
air
liquid
interfac
cultur
apic
surfac
wash
twice
hank
balanc
salt
solut
hbss
remov
mucu
viru
stock
dilut
hbss
hae
infect
absolut
infecti
dose
pfu
cell
incub
h
co
atmospher
humid
adsorpt
viru
dilut
remov
well
wash
three
time
hbss
sampl
taken
indic
time
point
appli
hbss
apic
surfac
minut
prior
actual
time
point
basolater
medium
exchang
hpi
assess
proteas
activ
conduct
transcleavag
assay
cellsml
seed
plate
h
prior
transfect
ng
plpencod
plasmid
coexpress
ng
sarscov
substrat
h
cell
lyse
lysi
buffer
mm
tri
ph
mm
nacl
mm
egta
mm
edta
triton
mm
na
pyrophosph
mm
mm
na
orthovanad
mgml
leupeptin
mm
pmsf
lysat
separ
sdspage
use
semidri
transfer
blotter
protein
transfer
membran
block
dri
milk
tbst
buffer
nacl
mm
trishcl
ph
tween
h
room
temperatur
membran
incub
rabbitantibodi
direct
gfpepitop
tag
thermofish
scientif
membran
wash
three
time
min
tbst
buffer
next
membran
incub
hrpcoupl
donkey
antirabbit
secondari
antibodi
southernbiotech
h
membran
wash
three
time
min
tbst
buffer
confirm
plp
express
membran
probe
mous
antiflag
sigmaaldrich
follow
goat
antimous
hrpcoupl
southernbiotech
antibodi
mous
sigmaaldrich
use
detect
host
cell
protein
load
control
secondari
detect
perform
use
goat
antimous
hrp
antibodi
southernbiotech
assay
perform
use
cell
black
plate
clear
bottom
cell
transfect
ng
ng
plpexpress
plasmid
use
fugen
hd
promega
accord
manufactur
instruct
hour
post
transfect
hpt
cell
equilibr
glosensor
reagent
promega
inhibitor
quantif
cell
equilibr
hpt
glosensor
reagent
indic
hpt
dilut
inhibitor
dmso
ad
luminesc
measur
h
follow
h
data
analysi
fold
luciferas
induct
calcul
independ
plp
calibr
valu
obtain
everi
time
point
respect
start
valu
cell
cellsml
transfect
format
ng
haubiquitin
haub
ng
plpexpress
plasmid
use
transfect
reagent
miru
hpt
cell
treat
lysi
buffer
protein
separ
sdspage
analyz
western
blot
describ
western
blot
analysi
done
use
mous
antiha
serum
covanc
goat
antimous
hrp
southernbiotech
antibodi
cell
transfect
plasmid
encod
mycepitop
tag
ng
conjug
machineri
compris
set
three
ligas
ng
ng
ng
plpencod
plasmid
cotransfect
amount
ng
h
cell
lyse
separ
sdspage
indic
extent
isgyl
cellular
protein
analyz
western
blot
use
mous
antimyc
mbl
life
scienc
goat
antimous
hrp
southernbiotech
antibodi
cellsml
transfect
plasmid
encod
renilla
rl
firefli
ff
luciferas
ff
luciferas
gene
control
promot
rl
luciferas
gene
clone
behind
herp
simplex
thymidinekinas
tk
promot
promot
activ
trigger
overexpress
cellular
led
autoactiv
ifn
pathway
transfect
dna
plasmid
done
fugen
hd
promega
accord
manufactur
instruct
plasmid
amount
given
plate
format
follow
prltk
ng
ng
ng
ng
plpexpress
plasmid
cell
lyse
hpt
luciferasecontain
lysat
transfer
opaqu
white
microtit
plate
use
assess
luciferas
activ
bioluminesc
detect
reader
transloc
assay
perform
describ
elsewher
briefli
cell
transfect
plasmid
encod
ng
either
ev
ng
flagtag
plpexpress
plasmid
use
fugen
hd
promega
activ
ifn
pathway
cell
infect
rvfv
cl
moi
hpt
hpi
cell
fix
paraformaldehyd
permeabil
immunofluoresc
analysi
done
sampl
transfect
ev
treat
antirvfv
mous
serum
friedemann
weber
univers
goat
antimous
dianova
gmbh
secondari
antibodi
plpexpress
cell
stain
mous
antiflag
sigmaaldrich
goat
antimous
dianova
gmbh
antibodi
sampl
analyz
fluoresc
microscop
zeiss
depend
number
transfect
cell
least
three
imag
taken
number
cell
doubleposit
gfp
flag
divid
number
cell
show
nuclear
transloc
cellsml
seed
plate
h
prior
infect
serial
dilut
sampl
gener
dilut
ad
cell
incub
h
adsorpt
viru
sampl
remov
overlay
avicel
dilut
dmem
ad
well
overlay
discard
day
post
infect
dpi
cell
fix
min
formaldehyd
cell
wash
pb
stain
crystal
violet
work
solut
min
plaqu
form
unit
determin
least
two
dilut
distinct
plaqu
detect
viral
rna
extract
nucleospin
rna
viru
isol
kit
machereynagel
manufactur
instruct
viral
rna
appli
reaction
quantif
genom
sarscov
rna
done
use
superscript
iii
onestep
revers
transcriptasepcr
system
invitrogen
platinum
taq
dna
polymeras
accord
manufactur
recommend
primer
sarsf
sarsp
sarsr
establish
sarscov
standard
curv
use
run
quantifi
rna
copi
per
ml
analyz
express
rhinolophu
alcyon
cell
provid
author
christian
drosten
marcel
mrna
extract
nucleospin
rna
isol
kit
machereynagel
realtim
pcr
done
describ
previous
use
follow
primer
rhinolophu
alcyon
determin
induct
rel
tbp
rhinolophu
alcyon
method
appli
phylogenet
analysi
perform
use
neighbor
join
algorithm
geneiou
assumpt
tamuranei
genet
distanc
model
align
done
base
amino
acid
code
algorithm
geneiou
softwar
packag
ident
similar
list
protein
calcul
amino
acid
align
use
substitut
matrix
threshold
support
inform
fig
analysi
srplp
splice
product
western
blot
analysi
cell
transfect
plasmid
express
nonoptim
srplp
detect
potenti
splice
product
aminoterminu
contain
flagand
carboxyterminu
contain
hatag
protein
express
confirm
western
blot
analysi
use
flagor
haspecif
antibodi
produc
mous
respect
secondari
detect
done
use
antimous
antibodi
coupl
horseradish
peroxidas
produc
goat
tif
fig
compar
inhibit
rscv
chimer
srplprscv
compound
number
viabl
cell
inhibitor
treatment
determin
luminescencebas
cell
viabil
assay
therefor
vero
cell
seed
opaqu
plate
h
cell
incub
either
dmso
serial
dilut
compound
use
dmem
diluent
h
detect
reagent
ad
incub
anoth
min
emit
luminesc
record
detect
reader
integr
time
tif
tabl
primer
clone
construct
use
heterolog
express
analyz
tabl
primer
amplif
sequenc
soplp
forward
primer
rev
revers
primer
singlelett
code
system
degener
base
establish
intern
union
pure
appli
chemistri
iupac
use
definit
docx
